GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr | ₹955 Cr |
What is the latest Operating Profit of GLAND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,333 Cr |
| Mar2024 | ₹1,025 Cr |
| Mar2023 | ₹1,510 Cr |
| Mar2022 | ₹1,302 Cr |
| Mar2021 | ₹955 Cr |
How is Operating Profit of GLAND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,333 Cr | 30.09 | |
| Mar2024 | ₹1,025 Cr | -32.14 | |
| Mar2023 | ₹1,510 Cr | 15.97 | |
| Mar2022 | ₹1,302 Cr | 36.29 | |
| Mar2021 | ₹955 Cr | - | |
Compare Operating Profit of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹40,058.7 Cr | -2.3% | 4.9% | 18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -2.3% |
4.9% |
18.9% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses